Virology
Common vaccines destroy cancer cells
Published in Gene Therapy Weekly, August 4th, 2005
According to recent research from the United States, "oncolytic viruses are promising cytoreductive agents for cancer treatment but extensive human testing will be required before they are made commercially available. Here, we investigated the oncolytic potential of two commercially available live attenuated vaccines, Moraten measles and Jeryl-Lynn mumps, in a murine model of intraperitoneal human ovarian cancer and compared their efficacies against a recombinant oncolytic measles virus (MV-CEA) that is being tested in a phase I clinical trial."
"The common feature of these viruses is that they express...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2005-08-04)
More Articles from Gene Therapy Weekly
- Cardiology
Cell-based gene therapy stimulates angiogenic receptors in the myocardium - Liver Cancer
Small interfering RNA focuses on hepatocellular carcinoma oncoprotein - Liver Cancer
Soluble VEGF receptor gene therapy abates liver tumor growth - Neuroscience
Re-engineered neural stem cells use a bystander effect to target glioma - Alzheimer Disease
Alzheimer disease examined, amyloid-beta implicated in metal homeostasis - Alzheimer Disease
Water-soluble amyloid-beta studied, role in Alzheimer disease revealed - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
